Hemocromatose hereditária: Relate de caso e revisão da literatura

Arquivos de Gastroenterologia

Volumn 38, Issue 3, 2001, Pages 194-202

  De Souza, Aécio FlávioMeirelles ^a   Carvalho Filho, Roberto J ^b   Chebli, Júlio Fonseca ^b  

^a NONE   (Brazil)

^b NONE

Author keywords

Hemochromatosis; Iron overload

Indexed keywords

ADULT; CASE REPORT; FEMALE; GENETICS; HEMOCHROMATOSIS; HUMAN; PROGNOSIS; REVIEW;

ADULT; FEMALE; HEMOCHROMATOSIS; HUMANS; PROGNOSIS;

EID: 0038895751     PISSN: 00042803     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-28032001000300010     Document Type: Article

References (32)

1. Adams P, Brissot P, Powell LW. EASL International Consensus Conference on Haemochromatosis. J Hepatol 2000;33:485-504.
2. Andrews NC. Disorders of iron metabolism. N Engl J Med 1999;341:1986-98.
3. Bacon BR, Tavill AS. Hemochromatosis and the iron overload syndromes. In: Zakim D, Boyer TD, editors. Hepatology - a textbook of liver disease. 3.ed. Philadelphia: W.B. Saunders; 1997. v.2, p. 1439-72.
4. Bacon BR, Britton RS. Hereditary hemochromatosis. In: Feldman M, Scharschmidt BF, Sleisenger MH, editors. Sleisenger & Fordtran's gastrointestinal and liver disease - pathophysiology/diagnosis/management. 6. ed. Philadelphia: W.B. Saunders; 1998. p.1097-103.
5. Bhavnani M, Lloyd D, Bhattacharyya A, Marples J, Elton P, Worwood M. Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferasis. Gut 2000;46:707-10.
6. Bothwell TH, MacPhail AP. Hereditary hemochromatosis: etiologic, pathologic, and clinical aspects. Sem Hematol 1988;35:55-71.
7. Brissot P, Moirand R, Guyader D, Loréal O, Turlin B, Deugnier Y. Hemochromatosis after the gene discovery: revisiting the diagnostic strategy. J Hepatol 1998;28:14-8.
8. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 1996;335:1799-805.
9. Catterson PR, Summerfield GP, Beesley JF. Interpretation of iron studies in adolescent haemochromatosis. Clin Lab Haematol 1999;21:129-31.
10. Chapoutot C, Esslimani M, Joomaye Z, Ramos J, Perney P, Laurent C, Fabbro-Peray P, Larrey D, Domergue J, Blanc F. Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis. Gut 2000;46:711-4.
11. Deugnier Y, Turlin B, Loréal O. Iron and neoplasia. J Hepatol 1998;28:21-5.
12. El-Serag HB, Inadomi JM, Kowdley KV. Screening for hereditary hemochromatosis in siblings and children of affected patients. A cost-effectiveness analysis. Ann Intern Med 2000;132:261-9.
13. Fairbanks VF, Baldus WP. Iron overload (hemochromatosis). In: Bennett JC, Plum F, editors. Cecil textbook of medicine. 20.ed. Philadelphia: W.B. Saunders; 1996. p.1132-5.
14. Fargion S, Mandelli C, Piperno A, Cesana B, Fracanzani AL, Fraquelli M. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 1992;15:655-9.
15. Farrell FJ, Nguyen M, Woodley S. Outcome of liver transplantation in patients with hemochromatosis. Hepatology 1994;20:404.
16. Feder JN, Gnirke A, Thomas W. A novel MHC class-I like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
17. Florkowsky CM, George PM, Willis JA. Haemochromatosis gene mutations Cys282Tyr and His63Asp are not increased in type 2 diabetic patients compared with the Canterbury (New Zealand) general population. Diabetes Res Clin Pract 1999;43:199-203.
18. Galizzi Filho J, Andrade MO. Doença de Wilson e hemocromatose. In: Parise ER, Porta G, editores. Manual de diagnóstico e tratamento das doenças hepáticas - no paciente adulto e pediátrico. São Paulo: 1999. p.145-57.
19. George DK, Rann GA, Walker NI. Elevated serum type IV collagen: a sensitive indicator of the presence of cirrhosis in haemochromatosis. J Hepatol 1999;31:47-52.
20. Goh J, Callagy G, McEntee G Hepatocellular carcinoma arising in the absence of cirrhosis in genetic haemochromatosis: three case reports and review of literature. Eur J Gastroenterol Hepatol 1999;11:915-9.
21. Kowdley KV, Kaplan MM. Iron-chelation therapy with oral deferiprone - toxicity or lack of efficacy? N Engl J Med 1998;339:468-9.
22. Niederau C, Erhardt A, Häussinger D, Strohmeyer G. Haemochromatosis and the liver. J Hepatol 1999;30:6-11.
23. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999;341:755-7.
24. Pietrangelo A, Montosi G, Totaro A, Garuti C, Conte D, Cassanelli S, Fraquelli M, Sardini C, Vasta F, Gasparini P. Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene. N Eng J Med 1999;341:755-7.
25. Powell LW. Genetic diagnosis of hemochromatosis: implications for prophylaxis and treatment. In: Arroyo V, Bosch J, Bruguera M, editors. Therapy in liver diseases. Barcelona: Masson; 1997. p.391-404.
26. Powell LW, Leggett BA, Crawford DHG Hemochromatosis and other iron storage disorders. In: Schiff ER, Sorrell MF, Maddrey WC, editors. Schiff's diseases of the liver. 8.ed. Philadelphia: Lippincott/Williams & Wilkins; 1999. v.2, p.1107-30.
27. Powell LW, Subramaniam N, Yapp TR. Haemochromatosis in the new millennium. J Hepatol 1999;32(suppl. 1):48-62.
28. Rossi E, Henderson S, Chin C. Genotyping as a diagnostic aid in genetic haemochromatosis. J Gastroenterol Hepatol 1999;14:427-30.
29. Tavill AS. Clinical implications of the hemochromatosis gene. N Engl J Med 1999;341:755-7.
30. Trousseau A. Glycosurie, diabete sucre. In: Anonymous clinique medicale de l'Hotel-Dieu de Paris. Z.ed. Paris: Bailliere; 1865. p.663.
31. Ten Kate J, Marell K, Huizinga R. Iron saturation of ferritin in the course of phlebotomy treatment in patients with haemochromatosis. Clin Chem Lab Med 1999;37:827-30.
32. von Recklinghausen FD. Uber Hamochromatose. Tagebl Versamml Natur Arzte Heidelberg 1889;62:324.